Published in Am J Med on July 01, 1976
Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13. Am J Hum Genet (1999) 0.82
Long term prognosis of recurrent haematuria. Arch Dis Child (1985) 0.77
Epstein's syndrome: case report and survey of the literature. Postgrad Med J (1987) 0.75
An unusual cause of renal failure; Epstein syndrome. J Nephropharmacol (2015) 0.75
Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med (1971) 8.22
Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol (1984) 3.72
Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature (1987) 3.63
Interaction between a "processed" ovalbumin peptide and Ia molecules. Proc Natl Acad Sci U S A (1986) 2.42
A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery (1978) 2.27
Twenty-five years of experience with out-center hemodialysis. Kidney Int (1999) 2.24
Policy interventions that attract nurses to rural areas: a multicountry discrete choice experiment. Bull World Health Organ (2010) 2.17
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89
Structural analysis of peptides capable of binding to more than one Ia antigen. J Immunol (1989) 1.85
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol (1997) 1.77
Mycoplasma pneumoniae-associated nephritis in children. Pediatr Nephrol (1999) 1.69
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
Adenocarcinoma arising from the gastrointestinal epithelium in benign cystic teratoma of the ovary. Gynecol Oncol (1998) 1.65
I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif. J Immunol (1988) 1.61
Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1988) 1.59
Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest (1982) 1.50
Clinical and laboratory findings of spotted fever in Israeli children. Pediatr Infect Dis J (1989) 1.47
Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45
The syndrome of abnormal chromatin clumping in leucocytes: a myelodysplastic disorder with proliferative features? Br J Haematol (1988) 1.42
[Can hydroxyethylamidon be used during intensive care of brain-dead organ donors?]. Ann Fr Anesth Reanim (1994) 1.40
Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39
Does diurnal variation in blood pressure exist in CAPD patients? Nephrol Dial Transplant (1994) 1.39
Defective synthesis of HbE is due to reduced levels of beta E mRNA. Nature (1980) 1.38
The patient with asymptomatic advanced renal failure--obstructive uropathy caused by inflammatory abdominal aortic aneurysm. Nephrol Dial Transplant (1998) 1.38
Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study. Isr J Med Sci (1990) 1.38
Comparison of anti-fading agents used in fluorescence microscopy: image analysis and laser confocal microscopy study. J Histochem Cytochem (1993) 1.37
T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron (1975) 1.37
Pharmacokinetics of atenolol in patients with renal impairment. Eur J Clin Pharmacol (1977) 1.35
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J (1989) 1.25
Serum beta2-microglobulin in hemodialyzed patients. Nephron (1978) 1.23
Pseudomembranous colitis probably due to rifampicin. Lancet (1980) 1.22
Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation. Diabetologia (1983) 1.22
Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int (1999) 1.20
Ultrasound imaging-guided noninvasive ultrasound thrombolysis: preclinical results. Circulation (2000) 1.20
The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol (1982) 1.19
Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo. J Immunol (1989) 1.19
Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation (1993) 1.18
Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem (1989) 1.18
Malignant hypertension with irreversible renal failure due to oral contraceptives. Br Med J (1975) 1.16
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res (1999) 1.15
Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med (2005) 1.15
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood (2000) 1.13
Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem (1981) 1.13
Listeria monocytogenes pericarditis in a chronically hemodialyzed patient. Am J Med Sci (1984) 1.12
Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol (1998) 1.12
The phospholipid and fatty acid composition of human platelet surface and intracellular membranes isolated by high voltage free flow electrophoresis. J Biol Chem (1982) 1.12
13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem (1985) 1.11
Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. J Comp Pathol (1997) 1.11
Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. J Pediatr (1995) 1.10
[Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy]. Presse Med (1984) 1.10
Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr (1996) 1.09
Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron (1987) 1.09
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke (1998) 1.08
Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett (1981) 1.08
Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol (1994) 1.06
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis (1975) 1.06
Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. J Clin Oncol (1998) 1.06
[Very severe colibacillus meningitis complicating post-abortum acute renal failure. Cure by ampicillin]. Lyon Med (1967) 1.06
Placental findings contributing to fetal death, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta (2009) 1.05
Increased renal prostaglandins in normal pregnancy and in pregnancy with hypertension. Nephron (1982) 1.05
Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol Med (1998) 1.05
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol (1999) 1.05
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res (1997) 1.04
Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am J Surg (1997) 1.04
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J Biol Chem (2000) 1.04
Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem (1992) 1.03
Activity of a new high efficiency diuretic in man: piretanide (HOE 118). Br J Clin Pharmacol (1980) 1.03
One-step procedure for the rapid isolation of mouse monoclonal antibodies and their antigen binding fragments by fast protein liquid chromatography on a mono Q anion-exchange column. J Chromatogr (1985) 1.03
Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids. Br J Clin Pharmacol (1988) 1.03
Studies of anti-lymphocyte globulins made from thoracic duct lymphocytes. Transplant Proc (1969) 1.02
Uremic optic neuropathy. A uremic manifestation mandating dialysis. Am J Nephrol (1998) 1.02
Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (1987) 1.02
Young-age onset of colorectal cancer in Israel. Tech Coloproctol (2009) 1.01
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys (1999) 1.01
Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer (1982) 1.01
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett (2009) 1.01
Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood (1994) 1.01
A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases. Histopathology (2006) 1.00
[Furosemide and renal failure. I. Use during acute renal failure]. Lyon Med (1971) 0.99
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Inhibition of the mixed lymphocyte reaction by antibodies. Transplant Proc (1972) 0.99
[Use in man of an anti-lymphocyte globulin: clincial results in renal transplantation]. Lyon Med (1968) 0.99
Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem (1983) 0.99
Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol (1993) 0.99
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. Biochem Biophys Res Commun (2005) 0.98
Pseudotumor cerebri and nitrofurantoin. Drug Intell Clin Pharm (1988) 0.98
Variant translocation in a non endemic case of Burkitt's lymphoma: t (8;22) in an Epstein--Barr virus negative tumour and in a derived cell line. Eur J Cancer (1981) 0.98
[Histomorphometric analysis of bone-marrow adipose density and heterogeneity in myeloid aplasia and dysplasia (author's transl)]. Pathol Biol (Paris) (1979) 0.98
Endocrinometabolic effects of whole versus segmental pancreas allotransplantation in diabetic patients--a two-year follow-up. Transplantation (1991) 0.97
Metabolic control of type I (insulin dependent) diabetes after pancreas transplantation. Br Med J (Clin Res Ed) (1985) 0.97
Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis. Am J Kidney Dis (1999) 0.97